PLCH1 overexpression promotes breast cancer progression and predicts poor prognosis through the ERK1/2-EGR1 axis
BackgroundPhospholipase C η1 (PLCH1), a member of the phospholipase C superfamily, has been implicated in the development of multiple cancers. However, its specific role in breast cancer progression, its association with clinicopathological features, and its prognostic significance remain unclear.Me...
Saved in:
| Main Authors: | Jing Li, Fenge Jiang, Congcong Wang, Ping Sun, Lei Song, Jiannan Liu |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-05-01
|
| Series: | Frontiers in Oncology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2025.1577114/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Combining AdipoRon with Paclitaxel Unveils Synergistic Potential in Non-Small Cell Lung Cancer Cells via AMPK-ERK1/2 Signaling
by: Sanober Kafeel, et al.
Published: (2025-04-01) -
Combined experimental and computational analysis of DNA damage signaling reveals context‐dependent roles for Erk in apoptosis and G1/S arrest after genotoxic stress
by: Andrea R Tentner, et al.
Published: (2012-01-01) -
The role of ERK1/2 signaling in diabetes: pathogenic and therapeutic implications
by: Hanlin Xu, et al.
Published: (2025-05-01) -
Piezo1 deletion mitigates diabetic cardiomyopathy by maintaining mitochondrial dynamics via ERK/Drp1 pathway
by: Weipin Niu, et al.
Published: (2025-03-01) -
Targeting of AKT/ERK/CTNNB1 by DAW22 as a potential therapeutic compound for malignant peripheral nerve sheath tumor
by: Xiao‐Xiao Li, et al.
Published: (2018-09-01)